Gastrointestinal Safety of Cyclooxygenase-2 Inhibitors: A Cochrane Collaboration Systematic Review

This publication has 78 references indexed in Scilit:

• A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas
  Gastroenterology, 2006
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
  BMJ, 2006
• Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip
  Journal of International Medical Research, 2001
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000
• Efficacy and Tolerability of Meloxicam versus Piroxicam in Patients with Osteoarthritis of the Hip or Knee
  Clinical Drug Investigation, 1997
• THE RISKS AND COSTS OF UPPER GASTROINTESTINAL DISEASE ATTRIBUTABLE TO NSAIDS
  Gastroenterology Clinics of North America, 1996
• Meloxicam in Osteoarthritis: A 6-Month, Double-Blind Comparison with Diclofenac Sodium
  Rheumatology, 1996
• A Double-Blind Study to Compare the Efficacy and Safety of Meloxicam 15 mg with Piroxicam 20 mg in Patients with Osteoarthritis of the HIP
  Rheumatology, 1996
• A Six-Month Double-Blind Trial to Compare the Efficacy and Safety of Meloxicam 7.5 mg Daily and Naproxen 750 mg Daily in Patients with Rheumatoid Arthritis
  Rheumatology, 1996
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996